Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan
- 4 November 2013
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 16 (6) , 747-753
Abstract
End-stage renal disease (ESRD) is a common finding in systemic lupus erythematosus (SLE) and may contribute to mortality. The purpose of the study was to investigate the incidence of ESRD and all-cause mortality and their risk factors in patients newly diagnosed with SLE in Taiwan. This nationwide cohort study used data from the National Health Insurance Research Database. We identified 4130 newly diagnosed SLE patients at risk for ESRD during 2000-2002; among them, 103 developed ESRD by the end of 2008. Additional 412 age- and sex-matched incident ESRD non-SLE patients served as controls for the survival analysis. Of the newly diagnosed SLE patients, 2.5% developed ESRD. Age (adjusted hazards ratio [HR] 0.66 for each 1-year increase; 95% confidence interval [CI] 0.47-0.94) and male gender (adjusted HR 2.24; 95% CI 1.4-3.6) were significantly associated with ESRD development. Survival analysis conducted after ESRD development revealed a higher mortality risk among the older patients (HR 1.04; 95% CI 1.02-1.05). Survival analysis in the younger population (age < 40 years) after ESRD development revealed a significant mortality risk among SLE patients (HR 2.73; 95% CI 1.22-6.07). In the follow-up of newly diagnosed SLE patients in Taiwan, younger age and male gender were risk factors for ESRD development. After entering ESRD, these risk factors had different impacts on mortality. Despite the overall improvement in care of patients with lupus nephritis, survival is still poorer in the younger age population.Keywords
This publication has 34 references indexed in Scilit:
- Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006Arthritis & Rheumatism, 2011
- Nationwide population-based epidemiologic study of systemic lupus erythematosus in TaiwanLupus, 2010
- The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosusClinical Rheumatology, 2010
- Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization dataArthritis & Rheumatism, 2007
- Projecting the United States ESRD population: Issues regarding treatment of patients with ESRDKidney International, 2004
- Synchronised therapy and high‐dose cyclophosphamide in proliferative lupus nephritisJournal of Clinical Apheresis, 2002
- Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamideKidney International, 2000
- Renal Involvement in Systemic Lupus Erythematosus: A Study of 180 Patients from a Single CenterMedicine, 1999
- DIALYSIS AND TRANSPLANTATION IN PATIENTS WITH RENAL FAILURE DUE TO SYSTEMIC LUPUS ERYTHEMATOSUS. THE AUSTRALIAN AND NEW ZEALAND EXPERIENCEAustralian and New Zealand Journal of Medicine, 1987
- The Long-Term Clinical Course of Systemic Lupus Erythematosus in End-Stage Renal DiseaseNew England Journal of Medicine, 1983